1.1Solid nerve autograft bridge
Epineurial sutures join each end of the graft to a nerve stump. Longitudinal endoneurial channels in the graft guide axons across the gap.
Generated automatically. Not reviewed by a person. Not legal advice or an opinion.
Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.
Epineurial sutures join each end of the graft to a nerve stump. Longitudinal endoneurial channels in the graft guide axons across the gap.
Directional freezing followed by freeze-drying forms elongated pores in the chitosan sponge. The sponge sits with its pores parallel to the conduit axis so cells and axons can enter from the nerve stumps.
Purified type I collagen forms an insert around parallel removable pins. Withdrawing the pins leaves channels that guide cells and axons along the conduit axis.
Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.
A veterinary nerve repair conduit contains decellularized human placental connective tissue matrix in its central lumen. The proximal and distal ends have unfilled cuffs sized to receive the cut ends of a canine peripheral nerve. Sutures through the cuffs and outer nerve sheaths hold the nerve ends in place against the matrix-filled segment.
A molded chitosan tube forms the conduit wall and defines a straight central lumen. A hydrated plug of decellularized human placental connective tissue matrix occupies the central segment, with a short recess at each end for nerve insertion. The continuous wall contains the plug, and the end regions accept sutures that secure the nerve ends.
A crosslinked hyaluronic acid cryogel replaces the placental connective tissue matrix in the conduit lumen. The cryogel is molded as a cylindrical insert with interconnected pores and longitudinal channels formed by removable axial pins. The hydrated insert fits against the inner wall and ends short of both openings, where the nerve ends seat against its channel openings.
A 14 mm conduit has a 3 mm internal diameter and a 10 mm central insert containing decellularized human placental connective tissue matrix. Three parallel 0.5 mm bores run the full length of the insert, with their centers spaced 120 degrees apart on a 0.7 mm radius. The insert is centered axially, leaving a 2 mm cuff at each end. The bores provide continuous longitudinal paths between the two cuff recesses.
A conduit containing decellularized human placental connective tissue matrix carries two echogenic bands embedded in its outer wall at the boundaries of the filled segment. The bands contain dispersed glass microspheres and produce distinct echoes on a high-frequency ultrasound image. A longitudinal scan locates the filled segment and measures the distance between the two bands.
A machine vision station measures the conduit bore at both ends and the distance between the end faces. For a straight conduit with a uniform bore, software calculates the fill volume from the mean bore diameter and the conduit length minus the two specified cuff lengths. A motorized syringe dispenses a suspension of decellularized human placental connective tissue matrix while withdrawing its nozzle through the central segment. A balance compares the dispensed mass with a target calculated from the fill volume and measured suspension density.
Braided resorbable polyester filaments form the tubular wall, and a continuous inner coating defines the lumen. The lumen contains hydrated decellularized human placental connective tissue matrix.
Short cuffs at the proximal and distal ends receive the corresponding nerve stumps. Epineurial sutures secure each stump to its cuff, and decellularized human placental connective tissue matrix fills the lumen between the cut faces.
Milling and sieving produce particles of decellularized human placental connective tissue matrix. Hydrated particles occupy the lumen between the nerve stumps and expose matrix surfaces to infiltrating cells.
An acidified pepsin solution solubilizes decellularized human placental connective tissue matrix. The neutralized preparation fills the lumen as a liquid and gels as it warms to body temperature.
Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.
The placental tissue may be decellularized prior to obtaining the ECM.A · US 2015/0313948 A1 · ¶ 67
Porcine scaffolds are provided that include decellularized, porcine placental extracellular matrix.B · US 2023/0310707 A1 · abstract
An empty cell means only that no passage was reproduced there.
There remains a need in the art for collagen compositions for the treatment of oral lesions.A · US 2015/0313948 A1 · ¶ 3
In one aspect, provided herein are methods of treating individuals having an oral lesion, e.g., an oral lesion not caused by a dental procedure, comprising administering to said individual a composition comprising extracellular matrix (ECM), e.g., human placental ECM, or a composition comprising one or more ECM components.A · US 2015/0313948 A1 · ¶ 4
Placental membrane tissue exhibits anti-microbial properties due to the presence of β-3 defensins that act to prevent microbial colonization of the epithelial surface (Chopra & Thomas, 2013;B · US 2023/0310707 A1 · ¶ 6
There remains a need in the art, however, for wound-healing treatments with high clinical efficiency that overcome the inconsistencies of the commercially available human-sourced products.B · US 2023/0310707 A1 · ¶ 8
patent.fyi, US 2026/0355390 A1, claim 1, first published 2026-11-19T10:59:45-05:00, https://patent.fyi/US20260355390/, SHA-256 8313300bb1a04b04854767b9b7af0d9b16a6f19a55c49ba83e0a265ec928f277